rs36222275
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP6BS2
The NM_139027.6(ADAMTS13):c.2944G>A(p.Gly982Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00146 in 1,614,086 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/23 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_139027.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADAMTS13 | NM_139027.6 | c.2944G>A | p.Gly982Arg | missense_variant | 23/29 | ENST00000355699.7 | NP_620596.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADAMTS13 | ENST00000355699.7 | c.2944G>A | p.Gly982Arg | missense_variant | 23/29 | 1 | NM_139027.6 | ENSP00000347927 | A2 |
Frequencies
GnomAD3 genomes AF: 0.00114 AC: 173AN: 152210Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00109 AC: 274AN: 250462Hom.: 0 AF XY: 0.00113 AC XY: 153AN XY: 135700
GnomAD4 exome AF: 0.00150 AC: 2190AN: 1461758Hom.: 2 Cov.: 32 AF XY: 0.00146 AC XY: 1060AN XY: 727170
GnomAD4 genome AF: 0.00114 AC: 173AN: 152328Hom.: 0 Cov.: 32 AF XY: 0.00115 AC XY: 86AN XY: 74484
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Mar 13, 2024 | Variant summary: ADAMTS13 c.2944G>A (p.Gly982Arg) results in a non-conservative amino acid change located in the Thrombospondin type-1 (TSP1) repeat (IPR000884) of the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0011 in 250462 control chromosomes, predominantly at a frequency of 0.0019 within the Non-Finnish European subpopulation in the gnomAD database. c.2944G>A has been reported in the literature in individuals with suspected inherited bleeding disorders (Leinoe_2017). This report does not provide unequivocal conclusions about association of the variant with Thrombotic Thrombocytopenic Purpura. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 28748566, 27802307). ClinVar contains an entry for this variant (Variation ID: 1590075). Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Upshaw-Schulman syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Mar 17, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at